Physician profile
Michael Silva
NPI 1205029998
$26,605.05
in general payments reported to CMS, 2019-2025
31 companies · $5,977 in 2025
The $5,977 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $5,623 · 2020: $1,458 · 2021: $3,090 · 2022: $2,426 · 2023: $3,852 · 2024: $4,179 · 2025: $5,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,763 · Travel and Lodging: $4,370 · Consulting Fee: $3,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,762.86 |
| Travel and Lodging | $4,369.98 |
| Consulting Fee | $3,875.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $12,506.69 | 2019-2025 | Torus Stent Graft System, Endocross Device, Alto Abdominal Stent Graft System |
| Boston Scientific Corporation | $3,798.27 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $3,033.79 | 2019-2025 | Gore Viabahn Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis |
| Surmodics, INC. | $1,004.24 | 2021-2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Medtronic, INC. | $955.30 | 2022-2024 | Endurant Iis, Ellipsys Vascular Access System |
| Shockwave Medical, INC | $802.44 | 2020-2025 | |
| Silk Road Medical, INC. | $725.50 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Bard Peripheral Vascular, INC. | $580.52 | 2019-2024 | Venovo, Venclose Maven Catheter |
| Bolton Medical INC | $447.88 | 2019-2023 | Treo Abdominal Stent-Graft System |
| Cardiovascular Systems INC. | $441.63 | 2021-2022 | |
| Philips North America LLC | $368.64 | 2019-2025 | Azurion 7 M20 |
| Cook Medical LLC | $337.77 | 2023-2025 | Zilver Ptx, Advance, Cook |
| Penumbra, INC. | $265.24 | 2023-2024 | Indigo System |
| Atrium Medical Corporation | $197.96 | 2023 | Fusion Bioline Supported Vascular Grafts |
| Tactile Systems Technology INC | $151.71 | 2020-2024 | Flexitouch Plus, Entre Plus |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $144.23 | 2022 | |
| Cagent Vascular INC | $132.35 | 2023-2024 | Serrantor |
| Siemens Medical Solutions USA, INC. | $132.31 | 2020-2021 | |
| Medtronic Vascular, INC. | $126.34 | 2019 | |
| Smith+Nephew, INC. | $89.72 | 2020-2022 | |
| Baxter Healthcare | $84.54 | 2019 | |
| Abbott Laboratories | $74.93 | 2023-2025 | Esprit, Eterna, Diamondback Peripheral |
| Avenu Medical INC. | $73.61 | 2019 | |
| Polynovo North America LLC | $25.26 | 2023 | |
| Avinger INC. | $24.66 | 2023 | Pantheris |
| Sanara Medtech INC. | $22.27 | 2023 | Celleraterx |
| Kerecis Limited | $21.11 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kci USA, INC. | $18.67 | 2023 | Promogran Prisma, Activ.A.C., 3m Cavilon |
| Ge Healthcare | $17.47 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,500.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.